1. Home
  2. BRCB vs BNR Comparison

BRCB vs BNR Comparison

Compare BRCB & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BRCB

Black Rock Coffee Bar Inc.

HOLD

Current Price

$6.87

Market Cap

206.8M

Sector

N/A

ML Signal

HOLD

Logo Burning Rock Biotech Limited

BNR

Burning Rock Biotech Limited

HOLD

Current Price

$8.93

Market Cap

179.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRCB
BNR
Founded
2008
2014
Country
United States
China
Employees
2800
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
206.8M
179.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
BRCB
BNR
Price
$6.87
$8.93
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$24.83
N/A
AVG Volume (30 Days)
900.6K
12.8K
Earning Date
05-12-2026
06-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$30.74
$111.65
Revenue Next Year
$24.06
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.13
$2.88
52 Week High
$30.40
$41.72

Technical Indicators

Market Signals
Indicator
BRCB
BNR
Relative Strength Index (RSI) 30.72 24.38
Support Level $6.13 $7.99
Resistance Level $17.60 $9.70
Average True Range (ATR) 0.66 1.33
MACD 0.15 -0.70
Stochastic Oscillator 25.09 4.91

Price Performance

Historical Comparison
BRCB
BNR

About BRCB Black Rock Coffee Bar Inc.

Black Rock Coffee Bar Inc is an operator of guest-centric, drive-thru coffee bars offering premium caffeinated beverages and an elevated in-store experience crafted by its engaging baristas. The company offers wide variety of coffee from classic espresso-based drinks such as Lattes, Americanos, and Cappuccinos, as well as signature creations like the Caramel Blondie, Mexican Mocha, and Blackout. It offers a variety of savory and sweet items, including breakfast burritos, sausage cheddar sandwiches, banana bread, and glazed donut holes.

About BNR Burning Rock Biotech Limited

Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.

Share on Social Networks: